A novel HLA-DRα1-MOG-35-55 construct treats experimental stroke

Author： Benedek Gil   Zhu Wenbin   Libal Nicole   Casper Amanda   Yu Xiaolin   Meza-Romero Roberto   Vandenbark Arthur   Alkayed Nabil   Offner Halina  

Publisher： Springer Publishing Company

ISSN： 0885-7490

Source： Metabolic Brain Disease, Vol.29, Iss.1, 2014-03, pp. : 37-45

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

A novel HLA‐DRB1 allele, HLA‐DRB1*12:48

By  

HLA, Vol. 87, Iss. 3, 2016-03 ,pp. : 190-191

John Wiley & Sons Inc

Access to resources Recommend Favorite

Description of a novel HLA‐DQB1 allele, HLA‐DQB1*06:126, in the Saudi stem cell donor registry

By  

HLA, Vol. 87, Iss. 1, 2016-01 ,pp. : 58-59

John Wiley & Sons Inc

Access to resources Recommend Favorite

Gilt required for RTL550-CYS-MOG to treat experimental autoimmune encephalomyelitis

By Burrows Gregory  

Metabolic Brain Disease, Vol. 27, Iss. 2, 2012-06 ,pp. : 143-149

Springer Publishing Company

Access to resources Recommend Favorite

A novel HLA‐B allele, HLA‐B*35:269

By  

HLA, Vol. 87, Iss. 2, 2016-02 ,pp. : 107-109

John Wiley & Sons Inc

Access to resources Recommend Favorite

HLA‐A*02:513, a novel HLA‐A*02 allele

By  

HLA, Vol. 87, Iss. 5, 2016-05 ,pp. : 382-383

John Wiley & Sons Inc

Access to resources Recommend Favorite